Premarket evaluations of the IMDx C. difficile for Abbott m2000 assay and the BD Max Cdiff assay

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1423-1428

  Stellrecht, K A ^a   Espino, A A ^a   Maceira, V P ^a   Nattanmai, S M ^a   Butt, S A ^a   Wroblewski, D ^b   Hannett, G E ^b   Musser, K A ^b  

^a ALBANY MEDICAL CENTER   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABBOTT M2000 ASSAY; ARTICLE; BACTERIAL GENE; BD MAX CDIFF ASSAY; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DNA EXTRACTION; FALSE POSITIVE RESULT; GENE AMPLIFICATION; GENE IDENTIFICATION; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; LIMIT OF DETECTION; MEASUREMENT PRECISION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TCDA GENE; TCDB GENE; TCDBV GENE; BIOASSAY; CLOSTRIDIUM INFECTIONS; DIAGNOSTIC KIT; DIARRHEA; FECES; GENETICS; HUMAN; MICROBIOLOGY; MOLECULAR DIAGNOSIS; NUCLEIC ACID AMPLIFICATION; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

BACTERIAL PROTEIN; BACTERIAL TOXIN; DIAGNOSTIC KIT; ENTEROTOXIN;

BACTERIAL PROTEINS; BACTERIAL TOXINS; BIOLOGICAL ASSAY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; ENTEROTOXINS; FECES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84899562419     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03293-13     Document Type: Article

References (22)

1. Redelings MD, Sorvillo F, Mascola L. 2007. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg. Infect. Dis. 13:1417-1419. http://dx.doi.org/10.3201/eid1309.061116.
2. McDonald LC, Owings M, Jernigan DB. 2006. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg. Infect. Dis. 12:409-415. http://dx.doi.org/10.3201/eid1203.051064.
3. Carroll KC, Bartlett JG. 2011. Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu. Rev. Microbiol. 65:501-521. http://dx.doi.org/10.1146/annurev-micro-090110-102824.
4. Stamper PD, Alcabasa R, Aird D, Babiker W, Wehrlin J, Ikpeama I, Carroll KC. 2009. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J. Clin. Microbiol. 47:373-378. http://dx.doi.org/10.1128/JCM.01613-08.
5. Shain EB, Clemens JM. 2008. A new method for robust quantitative and qualitative analysis of real-time PCR. Nucleic Acids Res. 36:e91. http://dx.doi.org/10.1093/nar/gkn408.
6. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
7. Wroblewski D, Hannett GE, Bopp DJ, Dumyati GK, Halse TA, Dumas NB, Musser KA. 2009. Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens. J. Clin. Microbiol. 47:2142-2148. http://dx.doi.org/10.1128/JCM.02498-08.
8. de Boer RF, Wijma JJ, Schuurman T, Moedt J, Dijk-Alberts BG, Ott A, Kooistra-Smid AM, van Duynhoven YT. 2010. Evaluation of a rapid molecular screening approach for the detection of toxigenic Clostridium difficile in general and subsequent identification of the tcdC Delta117 mutation in human stools. J. Microbiol. Methods 83:59-65. http://dx.doi.org/10.1016/j.mimet.2010. 07.017.
9. Persson S, Jensen JN, Olsen KE. 2011. Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC. J. Clin. Microbiol. 49:4299-4300. http://dx.doi.org/10.1128/ JCM.05161-11.
10. George WL, Sutter VL, Citron D, Finegold SM. 1979. Selective and differential medium for isolation of Clostridium difficile. J. Clin. Microbiol. 9:214-219.
11. Wilson KH, Kennedy MJ, Fekety FR. 1982. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J. Clin. Microbiol. 15:443-446.
12. Sydnor ER, Lenhart A, Trollinger B, Avdic E, Maragakis LL, Carroll KC, Cosgrove SE. 2011. Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies. Infect. Control Hosp Epidemiol. 32:1133-1136. http://dx.doi.org/10.1086/662381.
13. Burnham CA, Carroll KC. 2013. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin. Microbiol. Rev. 26:604-630. http://dx.doi.org/10.1128/CMR.00016-13.
14. Planche T, Wilcox M. 2011. Reference assays for Clostridium difficile infection: one or two gold standards? J. Clin. Pathol. 64:1-5. http://dx.doi.org/10.1136/jcp. 2010.080135.
15. Brecher SM, Novak-Weekley SM, Nagy E. 2013. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin. Infect. Dis. 57:1175-1181. http://dx.doi.org/10.1093/cid/cit424.
16. Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P, Fang FC, Dascal A, Gerding DN, Nomura JH, Goering RV, Akerlund T, Weissfeld AS, Baron EJ, Wong E, Marlowe EM, Whitmore J, Persing DH. 2010. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J. Clin. Microbiol. 48:3719-3724. http://dx.doi.org/10.1128/JCM.00427-10.
17. Carman RJ, Wickham KN, Chen L, Lawrence AM, Boone JH, Wilkins TD, Kerkering TM, Lyerly DM. 2012. Glutamate dehydrogenase is highly conserved among Clostridium difficile ribotypes. J. Clin. Microbiol. 50:1425-1426. http://dx.doi.org/10.1128/JCM.05600-11.
18. Goldenberg SD, Gumban M, Hall A, Patel A, French GL. 2011. Lack of effect of strain type on detection of toxigenic Clostridium difficile by glutamate dehydrogenase and polymerase chain reaction. Diagn. Microbiol. Infect. Dis. 70:417-419. http://dx.doi.org/10.1016/j.diagmicrobio.2011.03.012.
19. Akerlund T, Persson I, Unemo M, Noren T, Svenungsson B, Wullt M, Burman LG. 2008. Increased sporulation rate of epidemic Clostridium difficile type 027/NAP1. J. Clin. Microbiol. 46:1530-1533. http://dx.doi.org/10.1128/JCM.01964- 07.
20. Borriello SP, Wren BW, Hyde S, Seddon SV, Sibbons P, Krishna MM, Tabaqchali S, Manek S, Price AB. 1992. Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect. Immun. 60:4192-4199.
21. von Eichel-Streiber C, Zec-Pirnat I, Grabnar M, Rupnik M. 1999. A nonsense mutation abrogates production of a functional enterotoxin A in Clostridium difficile toxinotype VIII strains of serogroups F and X. FEMS Microbiol. Lett. 178:163-168.
22. Cohen SH, Tang YJ, Hansen B, Silva J, Jr. 1998. Isolation of a toxin B-deficient mutant strain of Clostridium difficile in a case of recurrent C. difficile-associated diarrhea. Clin. Infect. Dis. 26:410-412.